Tag Archives: LLY

Top 5 Safest Stocks To Invest In 2019

Companies hate to cut dividends. Knowing the backlash they’ll get from stockholders, many executives and board members consider it a desperate act of last resort. They will halt non-discretionary expenditures, reduce payroll and overhead, and even take on debt in order to maintain distributions.

And that’s exactly why dividend hikes send such a strong bullish signal. A company wouldn’t bump quarterly payouts to $0.60 per share from $0.50 unless it were fairly certain that incoming cash flows would be more than sufficient to cover the higher dividend, with room to spare. The last thing they want is to raise it today only to lower back down tomorrow. A dividend hike is a clear vote of confidence for future success.

—Sponsored Link— He Taught 3rd Graders How To Invest In 3 Easy Steps
While financial “experts” use industry jargon to confuse you, one former chemical engineer set out to do something radically different. Using three easy steps, he successfully boiled investing down to a language and a system that even a 3rd-grader can understand. So if an elementary student can learn to use his strategy effectively, imagine the incredible power it could have in your hands… Full story here.

As you may know, one feature of my premium High-Yield Investing newsletter is a screen for double-digit yielders. As part of my mission to scour the investing universe to find the highest and safest income screens for my premium subscribers, this is just one feature we use to identify potential future additions to our portfolio.

Top 5 Safest Stocks To Invest In 2019: Sempra Energy(SRE)

Advisors’ Opinion:

  • [By Tyler Crowe]

    Sempra Energy’s (NYSE:SRE) acquisition of Oncor was a bit of a coup on Wall Street, as it was able to outbid Berkshire Hathaway for the Texas utility. The victory didn’t come cheap, though, as Sempra had to cough up $9.5 billion and take on quite a bit of debt in the process of completing the deal. Even though the company sees immense potential in the purchase and the growth opportunities that come with it, shares of Sempra have been mostly flat for the past year.

  • [By Max Byerly]

    Sempra Energy (NYSE:SRE) was downgraded by Wells Fargo & Co to a “hold” rating in a research note issued on Tuesday.

    Other analysts also recently issued research reports about the stock. Zacks Investment Research upgraded shares of Sempra Energy from a “hold” rating to a “buy” rating and set a $125.00 price objective for the company in a report on Wednesday, March 28th. ValuEngine upgraded shares of Sempra Energy from a “sell” rating to a “hold” rating in a report on Monday. TheStreet upgraded shares of Sempra Energy from a “c+” rating to a “b” rating in a report on Monday, May 7th. Scotiabank upgraded shares of Sempra Energy from a “sector perform” rating to an “outperform” rating in a report on Thursday, April 26th. Finally, Argus upgraded shares of Sempra Energy from a “hold” rating to a “buy” rating and set a $119.00 price target for the company in a report on Monday, May 21st. Five research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Sempra Energy presently has an average rating of “Buy” and a consensus price target of $120.70.

  • [By Steve Symington]

    As for individual stocks, Sempra Energy(NYSE:SRE) soared as an activist investor stepped in, while Boston Scientific (NYSE:BSX) gained on news of a potential takeover.

  • [By Matthew DiLallo]

    Shares of Sempra Energy (NYSE:SRE) took off on Monday, rising more than 15% at 10:30 a.m. EDT after leading shareholders Elliot Management and Bluescape Resources publicly pressed the company to undertake a strategic review.

Top 5 Safest Stocks To Invest In 2019: Randgold Resources Limited(GOLD)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Randgold Resources (GOLD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Maxx Chatsko]

    Nonetheless, there are many smaller players with slick investor presentations making promises of big rewards. That could sound intriguing if you’ve caught the gold bug, but it’s important to remember the risks involved when investing in the industry. Luckily, some gold stocks come with big red flags and flashing red lights. Here’s why investors might want to avoid Hecla Mining (NYSE:HL), Tahoe Resources (NYSE:TAHO), and Randgold Resources (NASDAQ:GOLD).

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss.
    Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings.
    Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
    Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results.
    Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday.
    BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
    Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
    Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results.
    Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates.
    Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings.
    Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share.
    Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m

Top 5 Safest Stocks To Invest In 2019: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news articles that may have effected Accern Sentiment Analysis’s rankings:

    Get Agenus alerts:

    Agenus Inc. (AGEN): Stock Have a Latest Story: (bitcoinpriceupdate.review) P/E and PEG Value Under Consideration Agenus Inc. (NASDAQ:AGEN) (nasdaqjournal.com) Sizzling Spotlight- Kohl’s Corporation (NYSE:KSS), Agenus Inc. (NASDAQ:AGEN), The Hartford Financial Services … (journalfinance.net) Checking on Key Pivot Levels for Agenus Inc. (NASDAQ:AGEN): Woodie Pivot at 3.175 (stocknewscaller.com) Watch List Stock Agenus Inc. (AGEN) (stockmarketstop.com)

    Shares of AGEN traded down $0.10 during trading hours on Friday, reaching $2.70. 6,890,759 shares of the company traded hands, compared to its average volume of 1,149,867. The firm has a market capitalization of $280.80 million, a P/E ratio of -2.20 and a beta of 1.70. Agenus has a 12-month low of $2.70 and a 12-month high of $6.19. The company has a current ratio of 2.16, a quick ratio of 2.16 and a debt-to-equity ratio of -0.11.

  • [By Shane Hupp]

    Shares of Agenus (NASDAQ:AGEN) dropped 9.8% during trading on Monday following a dissappointing earnings announcement. The stock traded as low as $3.30 and last traded at $3.32. Approximately 2,421,286 shares changed hands during mid-day trading, an increase of 53% from the average daily volume of 1,586,724 shares. The stock had previously closed at $3.68.

  • [By Logan Wallace]

    Agenus (NASDAQ:AGEN) was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Monday.

  • [By Cory Renauer]

    Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

Top 5 Safest Stocks To Invest In 2019: Eli Lilly and Company(LLY)

Advisors’ Opinion:

  • [By Chris Lange]

    Eli Lilly and Co.s (NYSE: LLY) short interest decreased to 9.66 million shares from the previous 10.53 million. The stock was trading at $80.09. The 52-week range is $73.69 to $89.09.

  • [By ]

    Pharmaceutical stocks joined the party Wednesday after Trump dredged up drug pricing concerns during his State of the Union address. Every major drug manufacturer retreated yesterday. Eli Lilly & Co. (NYSE:LLY) led the way lower with a decline of more than 5%. Johnson & Johnson (NYSE:JNJ) and AbbVie (NYSE:ABBV) werent far behind with losses of 3%.

  • [By Chris Lange]

    Eli Lilly and Co.s (NYSE: LLY) short interest increased to 12.81 million shares from the previous 12.57 million. The stock was trading at $85.16. The 52-week range is $73.69 to $89.09.

  • [By Chris Lange]

    Eli Lilly and Co. (NYSE: LLY) is set to report its most recent results Tuesday morning as well. The analysts consensus estimates are $1.14 in EPS on revenue of $5.49 billion. Shares were changing hands at $79.06 on Fridays close. The consensus price target is $90.80, and the 52-week range is $73.69 to $89.09.

Top 5 Safest Stocks To Invest In 2019: Entercom Communications Corporation(ETM)

Advisors’ Opinion:

  • [By Daniel Sparks]

    Shares of radio broadcasting company Entercom Communications (NYSE:ETM) were slammed on Tuesday, falling as much as 24.1%. At the time of this writing, shares are down about 19%.

  • [By Ethan Ryder]

    Entercom Communications (NYSE:ETM) saw unusually large options trading activity on Thursday. Stock investors acquired 31,151 call options on the stock. This is an increase of 1,443% compared to the typical volume of 2,019 call options.

  • [By Money Morning News Team]

    Entercomm Communications Corp. (NYSE: ETM) is a Pennsylvania-based broadcasting and radio network corporation that was founded in 1968.

    The company owns 235 radio stations across 48 media markets and is the second-largest radio company in the United States. The company began its digital marketing arm in 2014 and announced the acquisition of Lincoln Financial Media the same year.

  • [By Lisa Levin]

    Entercom Communications Corp. (NYSE: ETM) shares dropped 18 percent to $8.75 following Q1 earnings.

    Shares of Hertz Global Holdings, Inc. (NYSE: HTZ) were down 17 percent to $18.505 after the company reported a wider-than-expected loss for its first quarter.

  • [By Max Byerly]

    Keeley Teton Advisors LLC increased its stake in Entercom Communications Corp. (NYSE:ETM) by 64.5% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 202,992 shares of the company’s stock after acquiring an additional 79,580 shares during the quarter. Keeley Teton Advisors LLC owned approximately 0.15% of Entercom Communications worth $1,959,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Entercom Communications (NYSE:ETM) was downgraded by research analysts at Noble Financial from a “buy” rating to a “hold” rating in a report released on Wednesday, The Fly reports.

Short Sellers Grow More Selective on Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study come back negative or a candidate not be approved. Conversely, if a drug gains FDA approval or passes a clinical trial, there can be big upside.

The White House has promised reforms in the health care sector, such as changing the bidding process for drugs and shortening the FDA approval process. It has yet to be seen how much headway they can actually make with these reforms.

Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay out the ongoing high dividends on top of the cost of borrowing the shares.

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.

Short interest in Pfizer Inc. (NYSE: PFE) decreased to 81.03 million shares from the previous 98.32 million. The stock was last seen trading at $37.06, within a 52-week range of $31.67 to $39.43.

The number of Merck & Co. Inc. (NYSE: MRK) shares short decreased to 22.95 million from 23.67 million in the previous period. Its shares were trading at $60.09, in a 52-week range of $52.83 to $66.41.

Teva Pharmaceutical Industries Ltd.s (NYSE: TEVA) short interest decreased to 55.84 million from the previous level of 59.40 million. Shares were trading at $17.56, in a 52-week range of $10.85 to $33.82.

Bristol-Myers Squibb Co. (NYSE: BMY) short interest increased to 14.32 million shares from the previous reading of 11.14 million. Shares were trading at $51.58, within a 52-week range of $50.66 to $70.05.

The number of shares short in AbbVie Inc. (NYSE: ABBV) increased to 15.66 million, compared to the previous 15.25 million. The stock was trading at $91.36, in a 52-week range of $64.61 to $125.86.

Eli Lilly and Co.s (NYSE: LLY) short interest decreased to 9.66 million shares from the previous 10.53 million. The stock was trading at $80.09. The 52-week range is $73.69 to $89.09.

ALSO READ: The 6 Most Shorted NYSE Stocks

Best Clean Energy Stocks To Invest In Right Now

Under Armour (NYSE:UA) (NYSE:UAA), Fitbit (NYSE:FIT), and GoPro (NASDAQ:GPRO) were all terrible stocks to own over the past year. Under Armour and Fitbit were both cut in half, and GoPro plummeted nearly 40%.

At first glance, Under Armour, Fitbit, and GoPro don’t have a lot in common, since they compete in different industries. But if we look just a little closer, we’ll notice that these three hated companies actually share four key weaknesses that won’t fade away anytime soon.

Image source: Getty Images.

1. Slowing sales growth in saturated markets

When Under Armour, Fitbit, and GoPro went public, investors were dazzled by their incredible sales growth. However, that euphoria faded as their markets became saturated and their sales growth slowed.

FY 2014

Best Clean Energy Stocks To Invest In Right Now: Eli Lilly and Company(LLY)

Advisors’ Opinion:

  • [By David Zeiler]

    Pharma stocks shot up in the wake of Donald Trump’s victory. Eli Lilly and Co. (NYSE: LLY) and Merck & Co. (NYSE: MRK) both rose about 6%, while Pfizer Inc. (NYSE: PFE) jumped 7%.

  • [By WWW.THESTREET.COM]

    Cramer recalled recently investing in Eli Lilly (LLY) on hopes the company’s Alzheimer’s research would be worth billions. As time has worn on, Lilly’s obstacles to success seem to be mounting. Not knowing if or when Lilly might see success, Cramer said he sold the stock and moved on.

  • [By Ben Levisohn]

    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

  • [By WWW.THESTREET.COM]

    That’s why Cramer said he’d use today’s weakness to buy Merck (MRK) , Eli Lilly (LLY) , Pfizer (PFE) and Allergan (AGN) , an Action Alerts PLUS holding.

  • [By Maxx Chatsko]

    Both Evenity and Tymlos are anabolic treatments, which means they encourage bone growth, rather than merely preventing bones from becoming more brittle, as prior generation osteoporosis drugs have done. While Eli Lilly (NYSE:LLY) was the first to market a drug in this class when Forteo gained marketing approval in 2002, it has faced no competitors despite achieving $1.5 billion in global sales last year, including $770 million in the United States. All of its patents expire by August 2019.

Best Clean Energy Stocks To Invest In Right Now: AVG Technologies N.V.(AVG)

Advisors’ Opinion:

  • [By Igor Novgorodtsev]

    InterActiveCorp (IACI) bought Ask.com for $1.85 billion in 2005. The new Perion will be worth only about 40% of that. After the merger, Perion will leapfrog its much larger rivals: Babylon and AVG (AVG). Finally, Perion should be able to increase its operating margins as it can spread its SG&A costs over a much larger base (Conduit EBITDA margin is 32% vs. Perion’s 23%). Perion will keep its senior management team intact: Josef Mandelbaum will remain its CEO and Yacov Kaufman its CFO. Perion has successfully orchestrated a roll-up acquisitions of privately-held Sweetpacks and Smilebox, so I have high confidence that they know how to integrate a new business.

Best Clean Energy Stocks To Invest In Right Now: American Financial Group, Inc.(AFG)

Advisors’ Opinion:

  • [By Lee Jackson]

    Aco-chief executive officer of American Financial Group Inc. (NYSE: AFG), Carl Linder, sold a total of 200,000 shares of the property and casualty insurance products provider at prices that ranged from $90.63 to $91.62. The total for the sale was set at $18 million. The shares closed Friday at $91.55, in a52-week range of $65.38 to $92.38. The consensus price target is $95.50.

Best Clean Energy Stocks To Invest In Right Now: Zion Oil & Gas Inc(ZN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Zion Oil & Gas, Inc. (NASDAQ: ZN) got a boost, shooting up 47 percent to $6.21.

    Spark Energy Inc (NASDAQ: SPKE) shares were also up, gaining 10 percent to $19.10. Guggenheim upgraded Spark Energy from Neutral to Buy.

  • [By Lisa Levin]

    In trading on Wednesday, energy shares fell by 0.76 percent. Meanwhile, top losers in the sector included Whiting Petroleum Corp (NYSE: WLL), down 6 percent, and Zion Oil & Gas, Inc. (NASDAQ: ZN) down 7 percent.

  • [By Lisa Levin]

    Shares of Zion Oil & Gas, Inc. (NASDAQ: ZN) got a boost, shooting up 20 percent to $5.07.

    Spark Energy Inc (NASDAQ: SPKE) shares were also up, gaining 12 percent to $19.40. Guggenheim upgraded Spark Energy from Neutral to Buy.

Best Clean Energy Stocks To Invest In Right Now: L Brands, Inc.(LB)

Advisors’ Opinion:

  • [By Teresa Rivas]

    L Brands (LB) ended at the bottom of the S&P 500 on Thursday, after disappointing guidance overshadowed better-than-expected earnings.

    L Brands slid $9.19, or 15.8%, to $48.94, its lowest close since 2013. By contrast, the S&P 500 gained 0.99 points, or 0.04%, today to 2363.81.

    Oppenheimers Anna Andreeva and Samantha Lanman reiterated an Outperform rating and $75 price target on the stock, but admit that the magnitude of L Brands downward forecast was disappointing, even with weak industry trends signaled by peers like Wal-Mart (WMT), Macys (M), and TJX Cos. (TJX).

    While they still are bullish, they admit that the bottom isnt clear:

    In the last 5 years, LB’s multiple averaged in high-teens given quality of brands/management, with 13-14x trough not seen since early ’13valuation could still compress assuming guidance isn’t conservative enough. Sticking with Outperform for now, albeit near-term visibility is worsening.

    L Brands is down 25% this year.

  • [By Chris Lange]

    With Christmas just around the corner and Black Friday already in the bag, holiday shopping is picking up. And this is especially true at L Brands Inc. (NYSE: LB), which recently reported its November sales.

  • [By Elizabeth Balboa]

    As tech falls, the once-forsaken shares of Gap Inc (NYSE: GPS), Macy’s Inc (NYSE: M), L Brands Inc (NYSE: LB), Costco Wholesale Corporation (NASDAQ: COST) and AT&T Inc. (NYSE: T) are surging.

  • [By WWW.THESTREET.COM]

    * The market bent yesterday but today it stabilized. (A good showing, all things being considered–but in no way decisive going forward).
    * Gold +$5/oz.
    * Crude oil +$0.50 and the rise is taking up some energy stocks.
    * The Russell returned to the spotlight.
    * Life insurance–particularly Lincoln National (LNC) (on an upgrade). Hartford Financial Services (HIG) gets a small lift.
    * Retail returned from the depths. The standouts–L Brands (LB) , Kohl’s (KSS) , Bed Bath (BBBY) , Nordstrom (JWN) and Gap (GPS) .
    * Ag equipment–after an analyst upgrade yesterday.
    * Brokerages.
    * Homebuilders catch a bid.
    * Day one of the Masters Golf Tournament.

Best Clean Energy Stocks To Invest In Right Now: TAL International Group Inc.(TAL)

Advisors’ Opinion:

  • [By Craig Jones]

    Instead of buying TAL Education Group (ADR) (NYSE: TAL), Cramer would buy Alibaba Group Holding Ltd (NYSE: BABA).

    Cramer thinks Burlington Stores Inc (NYSE: BURL) is going to have a good quarter, because Ross Stores, Inc. (NASDAQ: ROST) posted a good one, and they have similar business models.

Best Undervalued Stocks To Own For 2018

Our Long Idea reports aim to identify those firms that the market has overlooked and that, when analyzed beyond standard metrics, are significantly undervalued. These hidden gems provide excellent upside potential to any portfolio, with little downside risk.

In addition to individual Long Ideas, we provide Model Portfolios that provide well-screened lists of companies based on specific criteria such as return on invested capital (ROIC) or dividend yield. In 2016, we added two new Model Portfolios, Exec Comp Aligned With ROIC and Safest Dividend Yields, to go along with our longstanding Most Attractive & Most Dangerous Stocks Model Portfolio, which has a long history of outperformance.

Below presents the Long Idea highlights of 2016 and the performance of our new Model Portfolios.

Long Idea Highlights

It pays to read our Long Idea reports. In 2016, 10 out of our 15 Long Idea stock and mutual fund picks saw positive returns and 13 stocks outperformed the market (S&P 500). All told, the Long Idea stocks averaged a 9.9% return in 2016, which was slightly more than the S&P 500’s return of nearly 9.5%, thereby outperforming as a long portfolio. Some of the top picks can be seen in Figure 1 below.

Best Undervalued Stocks To Own For 2018: Popular, Inc.(BPOP)

Advisors’ Opinion:

  • [By Peter Graham]

    Founded in 1893, mid cap Popular Inc (NASDAQ: BPOP) is the leading banking institution by both assets and deposits in Puerto Rico and ranks among the top 50 U.S. banks by assets. Popular provides retail, mortgage and commercial banking services through its principal banking subsidiary, Banco Popular de Puerto Rico, as well as auto and equipment leasing and financing, investment banking, broker-dealer and insurance services through specialized subsidiaries. In the United States, Popular has established a community-banking franchise providing a broad range of financial services and products with branches in New York, New Jersey and Florida under the name of Popular Community Bank.

  • [By Ben Levisohn]

    We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).

Best Undervalued Stocks To Own For 2018: Cameco Corporation(CCJ)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, the Athabasca Basin is home to the McArthur River Uranium Mine -the worlds largest high-grade uranium deposit(accounting for 13% of world mine production) operated by mid cap uranium producer Cameco Corp (NYSE: CCJ).

  • [By Jim Robertson]

    Uranium was first discovered in the region in the 1940s with the first mine being the Rabbit Lake Mine which was discovered in 1968 by Gulf Mineral Resources and opened in 1975. The most important current mineisCameco Corps (NYSE: CCJ) McArthur River mine which isthe world’s largest high-grade uranium mine producing some 13% of global uranium production. Other important Athabasca Basin uranium mines include the Cigar Lake Mine, the Cluff Lake mine (now closed), the Key Lake mine and the McClean Lake mine plus the region continues to be an important center for uranium exploration for good reason as the following infographic illustrates:

Best Undervalued Stocks To Own For 2018: SodaStream International Ltd.(SODA)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    SodaStream International(NASDAQ:SODA) blew the market away in 2016 as shares of the DIY soda-maker popped 142%, beating all but two stocks in the S&P 500.

  • [By Peter Graham]

    Israel based small cap home beverage carbonation stockSodastream International Ltd (NASDAQ: SODA) reported Q1 2017 earnings before the market opened this morning. Revenue increased 14.3% to $115.3 million driven by growth in each of the Company’s four geographic regions, partially offset by a negative foreign currency exchange impact mainly due to the weakening of the Euro/U.S. Dollar exchange rate compared to the same period in 2016. Net income increased 141.8% to $14.7 million.

  • [By Peter Graham]

    Israel based small cap home beverage carbonation stockSodastream International Ltd (NASDAQ: SODA) reportedQ2 2017 earnings before the market opened on Wednesday. Revenue increased 9.6% to $130.6 millionwith theincrease driven by growth in most of the Company’s geographic regions -mainly Western Europe, partially offset by a negative foreign currency exchange impact mainly due to the weakening of the Euro/U.S. Dollar exchange rate compared to the same period in 2016. Net income increased approximately 84% to $14.4 million. As of June 30, 2017, the Company had cash and bank deposits totaling $108.5 million compared to $57.3 millionas ofDecember 31, 2016. The CEO commented:

Best Undervalued Stocks To Own For 2018: INC Research Holdings, Inc.(INCR)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of LEE THOMAS H PARTNERS LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=LEE+THOMAS+H+PARTNERS+LP

    These are the top 5 holdings of LEE THOMAS H PARTNERS LPINC Research Holdings Inc (INCR) – 25,174,838 shares, 38.1% of the total portfolio. New PositionParty City Holdco Inc (PRTY) – 65,157,952 shares, 25.55% of the total portfolio. West Corp (WSTC) – 18,099,239 shares, 12.29% of the total portfolio. MoneyGram International Inc (MGI) – 23,604,607 shares, 11% of the total portfolio. Fogo de Chao Inc (FOGO) – 17,053,123 shares, 6.12% of the total portfo

Best Undervalued Stocks To Own For 2018: Eli Lilly and Company(LLY)

Advisors’ Opinion:

  • [By Chris Lange]

    Eli Lilly & Co. (NYSE: LLY) saw its shares in free fall on Wednesday, not from the usual rhetoric of politicians or even the election, for that matter, but a late-stage trial failure. As 24/7 Wall St. has said time and again, clinical trials can make or break biotech and pharma companies. In this case Eli Lilly hit new 52-week lows, not seen since 2014 and this will not be a loss that Eli Lilly will easily forget. Effectively, the company announced results from its Phase 3 solanezumab trial in people with mild dementia due to Alzheimers disease (AD).

  • [By WWW.THESTREET.COM]

    Bond prices were much lower early in the day, with yields up by nearly 10 basis points. But fixed income has rallied back (reducing the drop by half on the day). Valeant Pharmaceuticals (VRX) , more weakness. Large pharma lower, led by Eli Lilly (LLY) . Old tech lags, with International Business Machines (IBM) , Intel (INTC) , Cisco Systems (CSCO) and Microsoft (MSFT) all lower. Media roughed up a bit (CBS (CBS) and Comcast (CMCSA) ). The Ugly
    Gold down another $23 to $1,188 (SPDR Gold Trust ETF (GLD) down $2.25). Urban Outfitters (URBN) down $5. NOTE: There will be no “Takeaways” today!   Happy Thanksgiving. Position: Long GLD small, SDS large, JCP large; short SPY, CSCO, CAT small, IWM, TLT small.

  • [By WWW.THESTREET.COM]

    Cramer recalled recently investing in Eli Lilly (LLY) on hopes the company’s Alzheimer’s research would be worth billions. As time has worn on, Lilly’s obstacles to success seem to be mounting. Not knowing if or when Lilly might see success, Cramer said he sold the stock and moved on.

  • [By David Zeiler]

    Pharma stocks shot up in the wake of Donald Trump’s victory. Eli Lilly and Co. (NYSE: LLY) and Merck & Co. (NYSE: MRK) both rose about 6%, while Pfizer Inc. (NYSE: PFE) jumped 7%.

  • [By Ben Levisohn]

    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

Best High Tech Stocks To Own Right Now

Source: Reuters

Check Point Software Technologies (NASDAQ:CHKP) reported better-than-expected earnings for the consecutive straight quarter, primarily due to strong subscription sales and introduction of innovative security solutions for the cloud, mobile and advanced threat prevention.

It last posted its earnings for Q12017 on April 27th. The company reported EPS of $1.20 for the quarter, topping Street estimates of $1.19 by $0.01. The company had revenue of $435 million for the quarter compared to the Street estimate of $432 million. During the same quarter in the prior year, the company posted adjusted EPS of $1.06. Currently, analysts expect CHKP to generate revenue of $454 million and EPS of $1.23 in Q22017. CHKP has a 12-month low of $74.34 and a 12-month high of $106.38 (CMP $105). The firm’s market cap is $17.55 billion.

Best High Tech Stocks To Own Right Now: Mitsubishi UFJ Financial Group Inc(MTU)

Advisors’ Opinion:

  • [By Jim Jubak, Senior Markets Editor, MoneyShow.com]

    The one currency that is running against the weak dollar tide is the Japanese yen. The yen initially climbed on the Fed’s no taper decision—rising to 97.75 on the news—but then fell all the way back to 99 yen to the dollar and finished yesterday at 99.42. (Remember that since the yen is quoted in yen to the dollar, a higher number is a sign of a weak yen and a smaller number means the yen is getting stronger.) The thinking seems to be that the recent Japanese trade deficit will push the Bank of Japan to further weaken the yen, in order to boost Japanese exports. I continue to think that the yen will finish 2013 at weaker levels than current trading, and that leads me to continue to hold positions in Japanese stocks such as Toyota Motor (TM) and Mitsubishi UFJ Financial Group (MTU). Both stocks are members of my Jubaks Picks portfolio.

Best High Tech Stocks To Own Right Now: (SIOLF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    China Life (NYSE:LFC) holds a 44 percent stake in China Guangfa Bank and a 30 percent stake in Sino-Ocean Group (OTCPK:SIOLF). Foresea owns large stakes in Gree Electric Appliances and China Vanke. If they are forced to sell their stakes, the Chinese stock market could see a sudden downturn.

Best High Tech Stocks To Own Right Now: Eli Lilly and Company(LLY)

Advisors’ Opinion:

  • [By David Zeiler]

    Pharma stocks shot up in the wake of Donald Trump’s victory. Eli Lilly and Co. (NYSE: LLY) and Merck & Co. (NYSE: MRK) both rose about 6%, while Pfizer Inc. (NYSE: PFE) jumped 7%.

  • [By WWW.THESTREET.COM]

    Bond prices were much lower early in the day, with yields up by nearly 10 basis points. But fixed income has rallied back (reducing the drop by half on the day). Valeant Pharmaceuticals (VRX) , more weakness. Large pharma lower, led by Eli Lilly (LLY) . Old tech lags, with International Business Machines (IBM) , Intel (INTC) , Cisco Systems (CSCO) and Microsoft (MSFT) all lower. Media roughed up a bit (CBS (CBS) and Comcast (CMCSA) ). The Ugly
    Gold down another $23 to $1,188 (SPDR Gold Trust ETF (GLD) down $2.25). Urban Outfitters (URBN) down $5. NOTE: There will be no “Takeaways” today!   Happy Thanksgiving. Position: Long GLD small, SDS large, JCP large; short SPY, CSCO, CAT small, IWM, TLT small.

  • [By WWW.THESTREET.COM]

    Cramer recalled recently investing in Eli Lilly (LLY) on hopes the company’s Alzheimer’s research would be worth billions. As time has worn on, Lilly’s obstacles to success seem to be mounting. Not knowing if or when Lilly might see success, Cramer said he sold the stock and moved on.

  • [By WWW.THESTREET.COM]

    That’s why Cramer said he’d use today’s weakness to buy Merck (MRK) , Eli Lilly (LLY) , Pfizer (PFE) and Allergan (AGN) , an Action Alerts PLUS holding.

  • [By Dimitra DeFotis]

    Shares of Eli Lilly (LLY) are down nearly 13% this morning after a late-stage Alzheimer’s drug trial failed to produce expected results.

    Biogen(BIIB), down nearly 6% today, also is working on an Alzheimer’s treatment; Merck (MRK) shareswere down 1% in recent trading.

    Lilly was testing the drug as a treatment for mild dementia due to Alzheimer’s disease.Credit Suisse analysts were hopeful the drug trial would show “a statistically significant impact on cognition.”MarketWatch reports:

    “Eli Lilly said it would not pursue approval for the drug to treat mild dementia due to Alzheimers disease and that it will ‘evaluate the impact of these results on the development plans for solanezumab and our other Alzheimers pipeline assets’ … More specifics about the solanezumab drug, expected the night of Dec. 9 during a meeting of the Clinical Trials on Alzheimers Disease (CTAD), could have repercussions for whats called the beta amyloid hypothesis in Alzheimers disease treatments, which target protein fragments that some believe are responsible for the disease …”

    On Nov. 15, J.P. Morgan analysts Chris Schott, Aditi Singhania, Dana Flanders and Christopher Neyor noted that trial success had a low probability. But they kept their$95 price target on the stock, noting the drug pipeline offers other opportunities. Their target implies upside of more than 40% from a recent price near $66. They wrote:

    “… On solanezumab … While the FDA recommends both cognitive and function endpoints for Alzheimers drug approvals, we expect the agency to review solanezumab on the totality of evidence, and we would not be surprised to see a cognitive benefit coupled with a trend in secondary functional endpoints be sufficient for approval … regardless of the solanezumab outcome, we see a diverse range of new product opportunities supporting LLY

  • [By Keith Speights]

    With this rapidly growing market, there are plenty of opportunities for investors. Zoetis (NYSE:ZTS), Merck (NYSE:MRK), and Eli Lilly (NYSE:LLY) stand out as the top animal-health companies to buy in 2017. Here’s why.